Last reviewed · How we verify
Calcipotriene and betamethasone suspension
Calcipotriene and betamethasone suspension is a Small molecule drug developed by Tolmar Inc.. It is currently in Phase 1 development. Also known as: Calcipotriene, betamethasone.
At a glance
| Generic name | Calcipotriene and betamethasone suspension |
|---|---|
| Also known as | Calcipotriene, betamethasone |
| Sponsor | Tolmar Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Calcipotriene and betamethasone suspension CI brief — competitive landscape report
- Calcipotriene and betamethasone suspension updates RSS · CI watch RSS
- Tolmar Inc. portfolio CI
Frequently asked questions about Calcipotriene and betamethasone suspension
What is Calcipotriene and betamethasone suspension?
Calcipotriene and betamethasone suspension is a Small molecule drug developed by Tolmar Inc..
Who makes Calcipotriene and betamethasone suspension?
Calcipotriene and betamethasone suspension is developed by Tolmar Inc. (see full Tolmar Inc. pipeline at /company/tolmar-inc).
Is Calcipotriene and betamethasone suspension also known as anything else?
Calcipotriene and betamethasone suspension is also known as Calcipotriene, betamethasone.
What development phase is Calcipotriene and betamethasone suspension in?
Calcipotriene and betamethasone suspension is in Phase 1.
Related
- Manufacturer: Tolmar Inc. — full pipeline
- Also known as: Calcipotriene, betamethasone